manual quickray® kit (Unitma Co Ltd)
90
Structured Review
Unitma Co Ltd
manual quickray® kit
Manual Quickray® Kit, supplied by Unitma Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/manual+quickray+kit/manual+quickray+kit/pm31043352-30-7-9
Average 90 stars, based on 1 article reviews
Manual Quickray® Kit, supplied by Unitma Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/manual+quickray+kit/manual+quickray+kit/pm31043352-30-7-9
Average 90 stars, based on 1 article reviews
manual quickray® kit - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Microarray:Article Title: Prevalence of targetable oncogenic mutations and genomic alterations in Epstein-Barr virus-associated diffuse large B-cell lymphoma of the elderly. Article Snippet: Following the initial description of 22 cases of Epstein–Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) in 2003 by Oyama et al., the 2008 revision of the World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues introduced the provisional entity of EBV-positive DLBCL of the elderly.. The presence of EBV-positive monoclonal large B-cell lymphoproliferation in an otherwise immunocompetent elderly patient constitutes the essential inclusion criterion for this type of tumor [1–3].. Despite the arbitrary nature of a specific cut-off, such as the exclusion of patients below the age of 50, it serves as an indicator of the markedly elevated incidence of this disease among the elderly and its rarity among younger patients [4]. Construct:Article Title: Prognostic implications of RASAL1 expression in oesophagogastric adenocarcinoma. Article Snippet: Activation of RAS signalling through the RAS-RAF-MEK-ERK cascade is a wellestablished event in various human cancers, leading to increased cell proliferation, inhibition of apoptosis and immortalisation of tumour cells.. 2 Recently, RASAL1 (RAS protein activator like 1), a RAS GTPaseactivating protein, which catalyses the inactivation of RAS, has been shown to act as a tumour suppressor in thyroid carcinoma, providing a potential alternative genetic background for tumours not harbouring ‘classical’ mutations in RAS or BRAF genes.. RASAL1 belongs to the so-called ‘RAS superfamily GTPases’ and has been reported to harbour somatic mutations exclusively in the RAS GTPase-activating domain, leading to impairment of suppression in the RAS-RAF-MEK-ERK cascade. |